ACM
SLNO

Aquatic Capital Management’s Soleno Therapeutics SLNO Stock Holding History

Aquatic Capital Management’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,572
Closed -$1.32M – 1779
2025
Q4 		$1.32M Buy
+28,572
New +$1.57M 0.04% 477
2025
Q3 		– Sell
-18,031
Closed -$1.51M – 1643
2025
Q2 		$1.51M Buy
+18,031
New +$1.35M 0.03% 549
2025
Q1 		– Sell
-29,208
Closed -$1.31M – 1600
2024
Q4 		$1.31M Buy
+29,208
New +$1.51M 0.04% 476
2024
Q3 		– Sell
-900
Closed -$36.7K – 1506
2024
Q2 		$36.7K Buy
+900
New +$38.1K ﹤0.01% 1049

Other funds holding SLNO

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.19B AUM 14.29% 1-Year Est. Return

Aquatic Capital Management's SLNO Position: Q1 2026 in Review

Aquatic Capital Management sold out of Soleno Therapeutics (SLNO) in Q1 2026, closing a stake of 28,572 shares — an estimated $1.32M sold.

Aquatic Capital Management first reported a position in SLNO in Q2 2024 and held it in 4 quarters. The position peaked at $1.51M in Q2 2025. 226 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

  • Aquatic Capital Management reported no remaining Soleno Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 28,572 Soleno Therapeutics shares in Q1 2026, an estimated $1.32M.
  • Aquatic Capital Management first reported a position in Soleno Therapeutics in Q2 2024 and held it in 4 quarters.
  • Aquatic Capital Management's Soleno Therapeutics position peaked at $1.51M in Q2 2025.
  • 226 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.